[French version of the article also available below.]
We are pleased to share with you an article published in Le Temps highlighting Pharmakina’s results and impact, as well as Roland Decorvet’s perspective on impact investing in Africa.
From Nestlé to pharmaceuticals in Congo, Roland Decorvet’s winning bet
Two years after acquiring a Congolese pharmaceutical company, Roland Decorvet, chairman of the board of directors of Pharmakina, and his teams have recorded the first positive results. Raising funds, however, remains a major challenge, as investments in Africa remain timid.
« In the first half of this year, we achieved a net profit margin of around 3% for the first time, while the EBITDA margin is around 15%. Annual revenue is expected to reach 14 million, representing a 40% increase year-on-year »
Read the full article here:
From Nestlé to pharmaceuticals in Congo..
Version française ici :
